Latest News about DSKYF

Recent news which mentions DSKYF

Latest Trial Setback For AstraZeneca's Dato-DXd, The Drug Fails To Extend Lives Of Pretreated Breast Cancer Patients

September 23, 2024

AstraZeneca's Investigational Cancer Drug Disappoints In Late-Stage Lung Cancer Trial

September 10, 2024

Recession-Resilient Asian Stock Picks: TSMC, SK Hynix Among This Analyst's Top 10

August 07, 2024

Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast

July 30, 2024

FDA Declines To Approve Merck-Daiichi Sankyo Partnered Lung Cancer Drug

June 27, 2024

5 Biotech Stocks With Key Catalysts This Week: Merck, Intellia, Verona, And More

June 24, 2024

Why Is AstraZeneca Stock Trading Lower On Tuesday?

May 28, 2024

Double Good News For AstraZeneca's Breast Cancer Drugs

April 29, 2024

AstraZeneca/Daiichi's Flagship Drug Enhertu Secures Accelerated FDA Approval For Pretreated Cancer Patients With Solid Tumor

April 08, 2024

What's Going On With Pfizer Stock Today?

January 25, 2024

Merck Signs Multi-Billion Deal With Japan's Daiichi Sankyo For Cancer Therapy Drug Development

October 20, 2023

Better Than Chemotherapy - AstraZeneca/Daiichi Sankyo Partnered Cancer Drug Meets Primary Goal In Breast Cancer Setting

September 22, 2023

AstraZeneca's Reinforces Hold In Lung Cancer Settings: Touts Promising Data From Three Trials

September 11, 2023

FDA Greenlights Daiichi Sankyo's Blood Cancer Drug, A Promising Competitor to Novartis' Rydapt

July 21, 2023

AstraZeneca Shares Under Pressure On Some Adverse Events In Late-Stage Lung Cancer Drug Trial

July 03, 2023

Daiichi, Zymeworks Terminate Seven Year-Cancer Antibody Pact

March 20, 2023

AstraZeneca-Daiichi Sankyo's Flagship Cancer Drug Shows Meaningful, Durable Responses In Other Solid Tumor Setting

March 06, 2023

Daiichi Sankyo Seeks Approval In Japan For Its mRNA-Based COVID-19 Vaccine

January 13, 2023

AstraZeneca - Daiichi Sankyo's Enhertu Wins European Approval For Gastric Cancer, CHMP Backs Other Cancer Drugs

December 19, 2022

European Medicines Agency's Advisory Committee Backs Approval Of AstraZeneca's Three Cancer Drugs

November 14, 2022

With Upcoming Contentious Meeting, This Analyst Cuts Price Target On Spectrum Pharma

September 21, 2022

Seagen Suffers Loss In Arbitration Dispute Over ADC Technology

August 15, 2022

AstraZeneca-Daiichi's Flagship Breast Cancer Drug Improves Survival In Late-Stage Study

August 15, 2022

Daiichi-AstraZeneca's Flagship Cancer Drug Scores FDA Approval For Lung Cancer Harboring HER2 Mutation

August 12, 2022

AstraZeneca's Dato-DXd-Based Combo Therapies Show Promising Activity In Lung Cancer Patients

August 09, 2022

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

July 19, 2022

AstraZeneca's Enhertu Wins European Approval For Pretreated Breast Cancer Setting

July 19, 2022

The Daily Biotech Pulse: CHMP Backs AstraZeneca's Breast Cancer Therapies, Ipsen Buys Epizyme, FDA Holds For Nuvation Bio, Astellas Studies

June 27, 2022

EMA's Advisory Committee Backs Approval For AstraZeneca's Targeted Breast Cancer Therapies

June 27, 2022

Morning Brief: Top Financial Stories Dominating on Monday, June 6

June 06, 2022

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.